SUMMARY Analytical subcellular fractionation techniques in combination with specific radioimmunoassays have been used to investigate the properties of the hormone-containing granules in human jejunal biopsy specimens. After gentle homogenisation, for all hormones except VIP, over 90% of the immunoreactivity was released in intact granules into the post-nuclear supernatant. Approximately 50% of the VIP immunoreactivity sedimented with the low speed pellet, probably reflecting the presence of this peptide in nerve fibres. The following hormone granules (equilibrium densities between parentheses) were separated by isopycnic centrifugation on the sucrose density gradients: VIP (1.17), motilin (1.20), and secretin (1.24). Gastrin and GIP granules were not resolved, both having the same modal density of 1'22 g/cm.3 This combination of procedures thus provides a new quantitative technique for studying the properties of the gastrointestinal hormone-containing granules, and should therefore be of value in investigating pathophysiological problems in a variety of gastrointestinal diseases.
With the development of accurate methods for measurement of gut hormones it has become apparent that there are characteristic abnormalities of the plasma gut hormone profile associated with various diseases of the human gastrointestinal tract.' Very little information, however, is as yet available about such fundamental aspects as the synthesis, storage, and mode of secretion of these hormones at the cellular level. Using the combined techniques of specific immunocytochemistry and electron microscopy it is now possible to identify the cells of origin of the gut hormones and recognise the hormone storage granules characteristic of each endocrine cell-type.2 However, while such studies give information as to the relative size and appearance of the granules, quantitative studies are not possible.
It has recently been shown that analytical subcellular fractionation procedures permit the quantitative assessment of the properties of individual subcellular organelles both in healthy and diseased tissues. Aliquots of the gradient fraction were mixed with an equal volume of 0.2 mol/1 HC1 to minimise proteolytic degradation of the hormones and kept deep frozen at -20°C until radioimmunoassay of hormone content. Freezing and thawing of the gradient samples in 0 1 mol/l HC1 after fractionation released the granule-bound hormones for radioimmunoassay.
RADIOIMMUNOASSAYS
Full details of radioimmunoassays for the gut hormones motilin,5 gastrin,6 secretin,7 gastric inhibitory peptide (GLP),8 and vasoactive intestinal peptide (VIP)9 have been reported elsewhere. All assays, except that for gastrin, were developed to the pure natural porcine hormones. In the case of gastrin, synthetic human gastrin I (ICI) was used. Antibodies to each hormone were raised in rabbits with the peptide coupled to bovine serum albumin by carbodiimide condensation. All antisera were tested for specificity by addition of up to 2 nmol per assay tube of all available gut hormones. In no case was any significant degree of cross-reactivity observed. The antibody dilutions routinely used and the assay sensitivities achieved are summarised in Table  1 . VIP, secretin, motilin, and GIP were all radioactively labelled with the lactoperoxidase technique,10 8 whereas a modification of the chloramine T method was used for gastrin.13 Because the quantities of tissue used in this study were extremely small all assays were specially modified and optimised for small sample addition using a total reaction volume of 200 ,ul. Each centrifugation gradient fraction was assayed at three separate dilutions (1/200, 1/20, and 1/4).
Protein content of the homogenates was assayed by the technique of Lowry et al.12 Protein in the subcellular fraction was assayed by the fluorimetric technique of Hiraoka and Glick.'3 Bovine serum albumin (Sigma, London) was used as a standard.
Results
In all cases the immunoreactive hormone content of the sucrose density gradient fractions diluted in parallel fashion to the respective standard curves. Sucrose at concentrations found in the density gradient fractions was found to have no effect on the assays. granules of such similar density as to prevent clear separation under these conditions. The conditions used here for the homogenisation of the biopsies and the subsequent intracellular fractionation appear to have been highly successful. In all cases, except for VIP, over 90% of the hormonal immunoreactivity was recovered from the post-nuclear supernatant fraction with little or no immunoreactivity being detectable in the low speed pellet, thus indicating that the cells were adequately disrupted to allow release of the hormone granules. Similarly, very little immunoreactivity was recovered in the low density 'soluble' region of the gradients, indicating that conditions were not so harsh as to cause significant disruption of the released granules. The presence of considerable quantities of VIP-like immunoreactivity in the low speed pellet could be explained by the fact that VIP occurs for the most part in fine nerve fibres and plexi both in the gut wall and mucosa.'6-'8 Thus the homogenisation conditions may not have been completely effective in the disruption of all the VIP-containing tissue. The VIP immunoreactivity seen here in the low speed pellets may thus reflect that present in nerve terminals, which would be expected to escape disruption under the conditions chosen and so would sediment with the larger cell debris.
There appears to be little correlation between the hormone granule densities reported here and the sizes of the granules determined by electron microscopy. Of those examined here, GIP granules in the human are the largest (350 nm)2 and intestinal gastrin granules the smallest (180-190 nm) 19 whereas these two granule types have similar centrifugation densities (1-22). Similarly secretin granules have a diameter of 250 nm2 and high modal density of 1-24 and motilin a diameter of 180-190 nm20 and density 1-20. However, in view of the fact that granule size depends on the fixation procedure employed, this lack of correlation is not surprising.
The data presented here are derived from jejunal biopsies taken from fasting subjects but clearly these techniques are readily applicable to other situations and other tissues. Thus it should be possible to study the dynamic changes in granule density in response to physiological stimuli. Similarly, possible granule alteration occurring in diseased states of the gut can also be readily studied. In view of the existence of different molecular forms of some of the gut hormones, in particular gastrin21 and enteroglucagon,22 these techniques have provided a unique opportunity to assess whether they are stored as single or multiple granules.
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